Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19766 | 426 | 30.7 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3754 | 694 | HLA B8 DR3//INTERDISCIPLINARY STUDIES SECT//AH 81 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTERDISCIPLINARY STUDIES SECT | Address | 2 | 36% | 1% | 4 |
2 | BIOL SCI TUNIS | Address | 1 | 50% | 0% | 1 |
3 | BLOOD TRANSFUS 1 | Address | 1 | 50% | 0% | 1 |
4 | CASE PARENT | Author keyword | 1 | 50% | 0% | 1 |
5 | CERVIX ABNORMALITIES | Author keyword | 1 | 50% | 0% | 1 |
6 | CLIN SEROL IMMUNOL | Address | 1 | 50% | 0% | 1 |
7 | DALIAN BLOOD | Address | 1 | 50% | 0% | 1 |
8 | DRB1 LOCUS | Author keyword | 1 | 50% | 0% | 1 |
9 | DRBI1302 | Author keyword | 1 | 50% | 0% | 1 |
10 | EUTIP | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CASE PARENT | 1 | 50% | 0% | 1 | Search CASE+PARENT | Search CASE+PARENT |
2 | CERVIX ABNORMALITIES | 1 | 50% | 0% | 1 | Search CERVIX+ABNORMALITIES | Search CERVIX+ABNORMALITIES |
3 | DRB1 LOCUS | 1 | 50% | 0% | 1 | Search DRB1+LOCUS | Search DRB1+LOCUS |
4 | DRBI1302 | 1 | 50% | 0% | 1 | Search DRBI1302 | Search DRBI1302 |
5 | HLA CW16 | 1 | 50% | 0% | 1 | Search HLA+CW16 | Search HLA+CW16 |
6 | HLA CW7 | 1 | 50% | 0% | 1 | Search HLA+CW7 | Search HLA+CW7 |
7 | HLA DP SUPERTYPE | 1 | 50% | 0% | 1 | Search HLA+DP+SUPERTYPE | Search HLA+DP+SUPERTYPE |
8 | HLA DQ DR | 1 | 50% | 0% | 1 | Search HLA+DQ+DR | Search HLA+DQ+DR |
9 | HLA DQB10501 | 1 | 50% | 0% | 1 | Search HLA+DQB10501 | Search HLA+DQB10501 |
10 | HLA DR BETA | 1 | 50% | 0% | 1 | Search HLA+DR+BETA | Search HLA+DR+BETA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DR DQ | 32 | 85% | 4% | 17 |
2 | HLA DQB1 ASTERISK 03 | 20 | 100% | 2% | 9 |
3 | HLA ASSOCIATED RISK | 8 | 100% | 1% | 5 |
4 | HLA POLYMORPHISMS | 1 | 50% | 0% | 2 |
5 | ANTIGEN CLASS I | 1 | 11% | 2% | 9 |
6 | BRITISH WOMEN | 1 | 17% | 1% | 4 |
7 | ANTIGEN FREQUENCIES | 1 | 21% | 1% | 3 |
8 | CELTIC ANCESTRY | 1 | 50% | 0% | 1 |
9 | DQB1 GENES | 1 | 50% | 0% | 1 |
10 | DRB1 ASTERISK 1001 | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
HLA and susceptibility to cervical neoplasia | 1999 | 51 | 22 | 41% |
HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease | 2005 | 22 | 122 | 25% |
Human leukocyte antigens and cancer: Is it in our genes? | 1999 | 28 | 52 | 27% |
EWINGS-SARCOMA IN FEMALE SIBLINGS - A CLINICAL REPORT AND REVIEW OF THE LITERATURE | 1984 | 12 | 1 | 100% |
Epidemiology of hepatocellular carcinoma in sub-Saharan Africa | 2013 | 6 | 28 | 11% |
HLA control in the progression of human papillomavirus infections | 1996 | 53 | 94 | 16% |
Lessons and implications from association studies and post-GWAS analyses of cervical cancer | 2015 | 0 | 134 | 16% |
CHRONIC LYMPHATIC-LEUKEMIA - AN INVESTIGATION OF HLA-ANTIGEN FREQUENCIES AND WHITE CELL DIFFERENTIAL COUNTS IN PATIENTS, RELATIVES AND CONTROLS | 1991 | 9 | 5 | 40% |
POLYGLANDULAR AUTOIMMUNITY | 1986 | 8 | 29 | 3% |
HLA AND DISEASE | 1984 | 4 | 256 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERDISCIPLINARY STUDIES SECT | 2 | 36% | 0.9% | 4 |
2 | BIOL SCI TUNIS | 1 | 50% | 0.2% | 1 |
3 | BLOOD TRANSFUS 1 | 1 | 50% | 0.2% | 1 |
4 | CLIN SEROL IMMUNOL | 1 | 50% | 0.2% | 1 |
5 | DALIAN BLOOD | 1 | 50% | 0.2% | 1 |
6 | EUTIP | 1 | 50% | 0.2% | 1 |
7 | GRP EPIDEMIOL GENET | 1 | 50% | 0.2% | 1 |
8 | HLA MOL BIOL | 1 | 50% | 0.2% | 1 |
9 | HLA TESTING | 1 | 50% | 0.2% | 1 |
10 | INTERBRANCH HUMAN LEUKOCYTE ANTIGEN | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000134605 | ARLTS1//HERITABLE CANCER//FAMILIAL RISK |
2 | 0.0000115734 | ANTIGEN PROCESSING MACHINERY//BIOQUIM BIOL MOL INMUNOL 3//HLA CLASS I |
3 | 0.0000084473 | HLA B8 DR3//AH 81//AGE VARIABILITY |
4 | 0.0000076825 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER |
5 | 0.0000073636 | PRAME//LEUKEMIA ASSOCIATED ANTIGENS//UNIT 900 |
6 | 0.0000072427 | TNF ALPHA GENE POLYMORPHISM//MOL LIFESCI//VA NEGOVSKY GEN REANIMATOL |
7 | 0.0000072282 | TISSUE ANTIGENS//ANTHONY NOLAN//BUDDHIST COMPASS RELIEF TZU CHI FDN |
8 | 0.0000064945 | CEITOX UNIDEF//DOSE DEPENDENT TRANSITIONS//PSYCH HLTH |
9 | 0.0000063245 | CELLULAR ONCOL//EMMY NOETHER GRP VIRUS ENDOCYTOSIS//PAPILLOMAVIRUS |
10 | 0.0000062848 | ANTI B CELL ANTIBODY//FOLLICULAR CENTER CELL//IN SITU IMMUNOPHENOTYPING |